UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 150

Sortiert nach

The genetics of the p53 pathway, apoptosis and cancer therapy

Nature reviews. Drug discovery, 2008-12, Vol.7 (12), p.979-987

2008

Volltextzugriff (PDF)

Expanding horizons: new roles for non-canonical RNA-binding proteins in cancer

Current opinion in genetics & development, 2018-02, Vol.48, p.112-120

2018

Volltextzugriff (PDF)

Genomic hallmarks and therapeutic implications of G0 cell cycle arrest in cancer

Genome Biology, 2023-05, Vol.24 (1), p.128-35, Article 128

2023

Volltextzugriff (PDF)

The importance of p53 pathway genetics in inherited and somatic cancer genomes

Nature reviews. Cancer, 2016-04, Vol.16 (4), p.251

2016

Volltextzugriff (PDF)

MDM2 is a central node in the p53 pathway: 12 years and counting

Current cancer drug targets, 2005-02, Vol.5 (1), p.3

2005

Volltextzugriff (PDF)

A Single Nucleotide Polymorphism in the MDM2 Promoter Attenuates the p53 Tumor Suppressor Pathway and Accelerates Tumor Formation in Humans

Cell, 2004-11, Vol.119 (5), p.591-602

2004

Volltextzugriff (PDF)

A Polymorphic p53 Response Element in KIT Ligand Influences Cancer Risk and Has Undergone Natural Selection

Cell, 2013-10, Vol.155 (2), p.410-422

2013

Volltextzugriff (PDF)

MEF2 transcription factors are key regulators of sprouting angiogenesis

Genes & development, 2016-10, Vol.30 (20), p.2297-2309

2016

Volltextzugriff (PDF)

A Polymorphic Antioxidant Response Element Links NRF2/sMAF Binding to Enhanced MAPT Expression and Reduced Risk of Parkinsonian Disorders

Cell reports (Cambridge), 2016-04, Vol.15 (4), p.830-842

2016

Volltextzugriff (PDF)

New role of fat-free mass in cancer risk linked with genetic predisposition

Scientific reports, 2024-03, Vol.14 (1), p.7270-7270, Article 7270

2024

Volltextzugriff (PDF)

MDM2 SNP309 accelerates tumor formation in a gender-specific and hormone-dependent manner

Cancer research (Chicago, Ill.), 2006-05, Vol.66 (10), p.5104-5110

2006

Volltextzugriff (PDF)

A single nucleotide polymorphism in the MDM2 gene : From a molecular and cellular explanation to clinical effect

Cancer research (Chicago, Ill.), 2005-07, Vol.65 (13), p.5481-5484

2005

Volltextzugriff (PDF)

iASPP mediates p53 selectivity through a modular mechanism fine-tuning DNA recognition

Proceedings of the National Academy of Sciences - PNAS, 2019-08, Vol.116 (35), p.17470-17479

2019

Volltextzugriff (PDF)

Venous identity requires BMP signalling through ALK3

Nature communications, 2019-01, Vol.10 (1), p.453-453, Article 453

2019

Volltextzugriff (PDF)

A High-Frequency Regulatory Polymorphism in the p53 Pathway Accelerates Tumor Development

Cancer cell, 2010-09, Vol.18 (3), p.220-230

2010

Volltextzugriff (PDF)

Germline Pathogenic Variants Impact Clinicopathology of Advanced Lung Cancer

Cancer epidemiology, biomarkers & prevention, 2022-07, Vol.31 (7), p.1450-1459

2022

Volltextzugriff (PDF)

Corrigendum: MEF2 transcription factors are key regulators of sprouting angiogenesis

Genes & development, 2022-10, Vol.36 (19-20), p.1096-1096

2022

Volltextzugriff (PDF)

Heritable genetic variants in key cancer genes link cancer risk with anthropometric traits

Journal of medical genetics, 2021-06, Vol.58 (6), p.392

2021

Volltextzugriff (PDF)

A common polymorphism in the retinoic acid pathway modifies adrenocortical carcinoma age-dependent incidence

British journal of cancer, 2020-04, Vol.122 (8), p.1231-1241

2020

Volltextzugriff (PDF)

A RASSF1A Polymorphism Restricts p53/p73 Activation and Associates with Poor Survival and Accelerated Age of Onset of Soft Tissue Sarcoma

Cancer research (Chicago, Ill.), 2012-05, Vol.72 (9), p.2206-2217

2012

Volltextzugriff (PDF)

Optimizing CRISPR/Cas9 Editing of Repetitive Single Nucleotide Variants

Frontiers in genome editing, 2022-07, Vol.4, p.932434-932434

2022

Volltextzugriff (PDF)

Single-nucleotide polymorphisms in the p53 signaling pathway

Cold Spring Harbor perspectives in biology, 2010-05, Vol.2 (5), p.a001032-a001032

2010

Volltextzugriff (PDF)

A genetic model for central chondrosarcoma evolution correlates with patient outcome

Genome medicine, 2022-08, Vol.14 (1), p.99-99, Article 99

2022

Volltextzugriff (PDF)

Comprehensive Landscape of Active Deubiquitinating Enzymes Profiled by Advanced Chemoproteomics

Frontiers in chemistry, 2019-08, Vol.7, p.592-592

2019

Volltextzugriff (PDF)

1 – 25 von 150

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(139)
Mit Volltextzugriff
(133)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(110)
Life Sciences & Biomedicine
(63)
Humans
(56)
Physical Sciences
(32)
Male
(27)
Female
(26)
Oncology
(25)
Animals
(22)
Chemistry
(22)
Adult
(21)
Polymorphism, Single Nucleotide
(19)
Middle Aged
(18)
Multidisciplinary Sciences
(17)
Science & Technology - Other Topics
(17)
Aged
(15)
Tumors
(15)
Cell Biology
(14)
Electrochemistry
(14)
Neoplasms - Genetics
(13)
Genetic Predisposition To Disease
(11)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The genetics of the p53 pathway, apoptosis and cancer therapy

Expanding horizons: new roles for non-canonical RNA-binding proteins in cancer

Genomic hallmarks and therapeutic implications of G0 cell cycle arrest in cancer

The importance of p53 pathway genetics in inherited and somatic cancer genomes

MDM2 is a central node in the p53 pathway: 12 years and counting

A Single Nucleotide Polymorphism in the MDM2 Promoter Attenuates the p53 Tumor Suppressor Pathway and Accelerates Tumor Formation in Humans

A Polymorphic p53 Response Element in KIT Ligand Influences Cancer Risk and Has Undergone Natural Selection

MEF2 transcription factors are key regulators of sprouting angiogenesis

A Polymorphic Antioxidant Response Element Links NRF2/sMAF Binding to Enhanced MAPT Expression and Reduced Risk of Parkinsonian Disorders

New role of fat-free mass in cancer risk linked with genetic predisposition

MDM2 SNP309 accelerates tumor formation in a gender-specific and hormone-dependent manner

A single nucleotide polymorphism in the MDM2 gene : From a molecular and cellular explanation to clinical effect

iASPP mediates p53 selectivity through a modular mechanism fine-tuning DNA recognition

Venous identity requires BMP signalling through ALK3

A High-Frequency Regulatory Polymorphism in the p53 Pathway Accelerates Tumor Development

Germline Pathogenic Variants Impact Clinicopathology of Advanced Lung Cancer

Corrigendum: MEF2 transcription factors are key regulators of sprouting angiogenesis

Heritable genetic variants in key cancer genes link cancer risk with anthropometric traits

A common polymorphism in the retinoic acid pathway modifies adrenocortical carcinoma age-dependent incidence

A RASSF1A Polymorphism Restricts p53/p73 Activation and Associates with Poor Survival and Accelerated Age of Onset of Soft Tissue Sarcoma

Optimizing CRISPR/Cas9 Editing of Repetitive Single Nucleotide Variants

Single-nucleotide polymorphisms in the p53 signaling pathway

A genetic model for central chondrosarcoma evolution correlates with patient outcome

Comprehensive Landscape of Active Deubiquitinating Enzymes Profiled by Advanced Chemoproteomics

Germline and Somatic Genetic Variants in the p53 Pathway Interact to Affect Cancer Risk, Progression, and Drug Response

Suchergebnisse filtern